Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Directly observed versus non-directly observed sulfadoxine-pyrimethamine intermittent preventive treatment in pregnancy at Jos University Teaching Hospital
PACTR202408866715915Not yet recruiting
- Sponsor
- Akor Andrew Onogwu
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by Akor Andrew Onogwu. Primary endpoints: Maternal malaria parasitemia at delivery and Packed cell volume at delivery. Planned start May 2024; status: not yet recruiting.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202408866715915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408866715915.